Compounded DHEA troche prepared per prescriber direction as part of an individualized hormone therapy plan. Prescription required.
Dehydroepiandrosterone (DHEA) Troche is a compounded dosage form prepared by HDRx according to individualized prescriber specifications, including customized strength and flavoring when appropriate. A valid prescription from a licensed healthcare provider is required.
DHEA is a naturally occurring hormone precursor that may be incorporated into provider-directed hormone therapy plans when clinically appropriate. A troche (lozenge) is designed for administration in the mouth, allowing absorption through the oral mucosa as directed by the prescribing professional.
Compounding enables healthcare providers to tailor hormone concentration and delivery format based on individualized monitoring and care considerations.
HDRx collaborates with medical providers to prepare customized hormone therapies for both men and women as part of comprehensive endocrine care planning. Learn more about our broader Hormone Therapies services, educational discussions on hormonal balance considerations in men and women, and related information on bioidentical hormone therapy planning.
You can also explore our overview of Women’s Health services for additional context regarding structured hormone care planning.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether this formulation is appropriate for their individual hormone care plan.
